CYRX vs XPOF

For growth investors, Xponential Fitness, Inc.

(XPOF) is the stronger pick with -1. 7% revenue growth year-over-year, versus -24. 5% for Cryoport, Inc. (CYRX). Cryoport, Inc. (CYRX) offers the better valuation at 9. 1x trailing P/E, making it the more compelling value choice. Analysts rate Cryoport, Inc. (CYRX) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Xponential Fitness, Inc.

(XPOF) delivered a total return of -46. 6%, compared to -79. 8% for Cryoport, Inc. (CYRX). Over 10 years, the gap is even starker: CYRX returned +557. 7% versus XPOF's -46. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cryoport, Inc.

(CYRX) is the lower-risk stock at 1. 84β versus Xponential Fitness, Inc. 's 1. 94β — meaning XPOF is approximately 5% more volatile than CYRX relative to the S&P 500.

By revenue growth (latest reported year), Xponential Fitness, Inc.

(XPOF) is pulling ahead at -1. 7% versus -24. 5% for Cryoport, Inc. (CYRX). On earnings-per-share growth, the picture is similar: Cryoport, Inc. grew EPS 163. 3% year-over-year, compared to 35. 2% for Xponential Fitness, Inc.. Over a 3-year CAGR, XPOF leads at 9. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cryoport, Inc.

(CYRX) is the more profitable company, earning 39. 9% net margin versus -10. 7% for Xponential Fitness, Inc. — meaning it keeps 39. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XPOF leads at 25. 3% versus -20. 9% for CYRX. At the gross margin level — before operating expenses — XPOF leads at 75. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for XPOF: 22.

3% to $8. 00.

In this comparison, XPOF (2.

5% yield) pays a dividend. CYRX does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Xponential Fitness, Inc.

(XPOF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2. 5% yield). Cryoport, Inc. (CYRX) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XPOF: -46. 6%, CYRX: +557. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CYRX (Industrials) and XPOF (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CYRX is a small-cap deep-value stock; XPOF is a small-cap quality compounder stock. XPOF pays a dividend while CYRX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.